The use of the Godin-Shephard Leisure-Time Physical Activity Questionnaire in oncology research: a systematic review.
Steve Amireault, Gaston Godin, Jason Lacombe...
https://pubmed.ncbi.nlm.nih.gov/26264621Actively Recruiting
Phase Not Applicable
Age: 18Years +
MALE
ID05214937
A Distance-based, Randomized Controlled Trial for Reducing Sedentary Behaviour Among Prostate Cancer Survivors
Led by University of Toronto · Updated on 2024-12-04
120
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
U
University of Toronto
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a 12-week behavioral intervention designed to reduce sedentary behavior among prostate cancer survivors (PCS). The study compares this intervention, which includes FitBit use and six behavioral support sessions guided by the Multi-Process Action Control (M-PAC) framework, to a control group that receives only a FitBit and access to public health physical activity resources. The study aims to measure changes in sedentary behavior immediately after the intervention and six months later, while also assessing impacts on physical activity, motivation, sleep quality, social support, physical function, quality of life, fatigue, disability, and mental health. Participants in the intervention group receive a FitBit Inspire 2 and six remote behavior change sessions delivered bi-weekly by a movement specialist, including four one-on-one sessions and two group webinars. They will monitor daily steps and work to increase their baseline step count progressively across phases. The control group receives the same FitBit device and an orientation session but only access to publicly available active living resources without additional behavioral support. The intervention sessions focus on planning, goal setting, social support, and habit formation based on the M-PAC theoretical framework. During the study, participants will wear activPAL inclinometers to objectively measure changes in sedentary behavior and physical activity at baseline, after the 12-week intervention, and at a 6-month follow-up. Self-reported sedentary behavior and physical activity will also be assessed using validated questionnaires. Researchers will monitor motivational factors, sleep, social support, physical function, and patient-reported outcomes such as quality of life, fatigue, disability, and mental health. The total participation involves these assessments across the intervention and follow-up periods, with data collected remotely.
CONDITIONS
Brief Title
A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors
Who Can Participate
Age: 18Years +
MALE
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Diagnosed with localized or asymptomatic metastatic primary prostate cancer
- Not currently undergoing radiation or chemotherapy
- Proficient in English
- Self-report less than 150 minutes of moderate-to-vigorous physical activity per week
- Self-report more than 8 hours of daily sedentary behaviour
- In the contemplation or preparation stage for motivational readiness to change
- Access to a smartphone, tablet, or computer
- No cardiac contraindications (e.g., unstable angina, arrhythmia, heart failure, aortic stenosis)
- Medical clearance from a primary health care provider if necessary
- Currently residing in Canada
You will not qualify if you...
- Not planning to live in Canada for the next 12 months
- Medical condition prohibiting walking (e.g., severe knee or hip arthritis)
- Presence of other primary or recurrent invasive cancer (except non-melanoma skin cancer)
- Had a prior fall within the last 12 months
- Use of a gait aid device
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (remote or in-person) for eligibility assessment
Baseline Period
Duration - 2 weeks
Participants maintain their regular movement routine to establish baseline daily average step count.
1 baseline visit with movement specialist and FitBit orientation
Intervention
Duration - 12 weeks
Participants receive a 12-week behavioural intervention involving self-regulatory strategies to reduce sedentary behaviour and increase daily step counts, supported by 6 remotely-delivered sessions including one-on-one and group webinars.
Bi-weekly remotely-delivered sessions totaling 6 sessions (4 one-on-one and 2 group webinars)
Follow-up
Duration - 6 months post-intervention
Participants are assessed at 6 months after the intervention to evaluate the maintenance of behaviour changes.
1 follow-up assessment visit
Trial Site Locations
Total: 1 location
1
University of Toronto
Toronto, Ontario, Canada, M5S 2W6
Actively Recruiting
Loading map...
Research Team
L
Linda Trinh, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Normative data for the 12 item WHO Disability Assessment Schedule 2.0.
Gavin Andrews, Alice Kemp, Matthew Sunderland...
https://pubmed.ncbi.nlm.nih.gov/20020047General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G).
Penny S Brucker, Kathleen Yost, John Cashy...
https://pubmed.ncbi.nlm.nih.gov/15851773What do self-efficacy items measure? Examining the discriminant content validity of self-efficacy items.
Alison M G Burrell, Julia L Allan, David M Williams...
https://pubmed.ncbi.nlm.nih.gov/29520897Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable.
Kristin L Campbell, Kerri M Winters-Stone, Joachim Wiskemann...
https://pubmed.ncbi.nlm.nih.gov/31626055The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
D F Cella, D S Tulsky, G Gray...
https://pubmed.ncbi.nlm.nih.gov/8445433Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65-80 years old? A psychometric evaluation study.
Ingrid Djukanovic, Jörg Carlsson, Kristofer Årestedt
https://pubmed.ncbi.nlm.nih.gov/28978356Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment.
B Gandek, J E Ware, N K Aaronson...
https://pubmed.ncbi.nlm.nih.gov/9817135Towards parsimony in habit measurement: testing the convergent and predictive validity of an automaticity subscale of the Self-Report Habit Index.
Benjamin Gardner, Charles Abraham, Phillippa Lally...
https://pubmed.ncbi.nlm.nih.gov/22935297A simple method to assess exercise behavior in the community.
G Godin, R J Shephard
https://pubmed.ncbi.nlm.nih.gov/4053261